DLB has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
DLB has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Dolby Laboratories's long-term debt to total assests ratio for the quarter that ended in Dec. 2024 was 0.01.
Dolby Laboratories's long-term debt to total assets ratio declined from Dec. 2023 (0.01) to Dec. 2024 (0.01). It may suggest that Dolby Laboratories is progressively becoming less dependent on debt to grow their business.
The historical data trend for Dolby Laboratories's LT-Debt-to-Total-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dolby Laboratories Annual Data | |||||||||||||||||||||
Trend | Sep15 | Sep16 | Sep17 | Sep18 | Sep19 | Sep20 | Sep21 | Sep22 | Sep23 | Sep24 | |||||||||||
LT-Debt-to-Total-Asset | Get a 7-Day Free Trial |
![]() |
![]() |
0.02 | 0.02 | 0.01 | 0.01 | 0.01 |
Dolby Laboratories Quarterly Data | ||||||||||||||||||||
Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | |
LT-Debt-to-Total-Asset | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Dolby Laboratories's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Sep. 2024 is calculated as
LT Debt to Total Assets (A: Sep. 2024 ) | = | Long-Term Debt & Capital Lease Obligation (A: Sep. 2024 ) | / | Total Assets (A: Sep. 2024 ) |
= | 34.754 | / | 3109.928 | |
= | 0.01 |
Dolby Laboratories's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2024 is calculated as
LT Debt to Total Assets (Q: Dec. 2024 ) | = | Long-Term Debt & Capital Lease Obligation (Q: Dec. 2024 ) | / | Total Assets (Q: Dec. 2024 ) |
= | 33.019 | / | 3158.602 | |
= | 0.01 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dolby Laboratories (NYSE:DLB) LT-Debt-to-Total-Asset Explanation
LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.
Thank you for viewing the detailed overview of Dolby Laboratories's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
Todd Pendleton | officer: SVP, Chief Marketing Officer | 1275 MARKET STREET, SAN FRANCISCO CA 94103 |
Ryan Nicholson | officer: VP, Corporate Controller | C/O DOLBY LABORATORIES INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103 |
Mark Andrew Sherman | officer: EVP, GEN. COUN. & SECRTY | DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103 |
Emily Rollins | director | C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103 |
Kevin J Yeaman | officer: VP, Chief Financial Officer | C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103 |
John D Couling | officer: SVP, Entertainment | C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103 |
Peter C Gotcher | director | |
Anjali Sud | director | C/O VIMEO INC., 555 WEST 18TH STREET, NEW YORK NY 10011 |
Simon Segars | director | C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103 |
Avadis Tevanian | director | DOLBY LABORATORIES INC, 1275 MARKET STREET, SAN FRANCISCO CA 94103 |
Shriram Revankar | officer: SVP, Advanced Technology Group | C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103 |
Tony A Prophet | director | 9 BERNICE STREET, SAN FRANCISCO CA 94103 |
Robert J Park | officer: SVP & Chief Financial Officer | C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103 |
Steven E Forshay | officer: Sr. Vice President, Research | 1275 MARKET STREET, SAN FRANCISCO CA 94103 |
Lewis Chew | officer: EVP, Chief Financial Officer | DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103 |
From GuruFocus
By GuruFocus News • 11-08-2024
By GuruFocus News • 11-20-2024
By GuruFocus News • 11-19-2024
By GuruFocus News • 11-20-2024
By PRNewswire • 02-19-2025
By GuruFocus News • 01-31-2025
By GuruFocus News • 01-28-2025
By PRNewswire • 01-13-2025
By PRNewswire • 01-07-2025
By GuruFocus News • 11-23-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.